fda warning letters glp-1 compounding october 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about compounded medications FDA Drug Recalls and Warnings:

The observation in this study in hepatocytes that protein-SSG formation by either GSSG accumulation or treatment with a direct S -glutathionylation induction agent resulted in IKK--SSG formation, leading to its suppression, was supported by a previous study reporting that S -glutathionylation was associated with suppressed IKK- activity in epithelial cells 41

J.HanninkM

New York authorities announced the results of a 2024 crackdown on illegal med spas

For blood routine tests, after anesthetizing the rats, the tip of the tail was cut to collect blood

Despite the known photoprotective effects of MT-II which are hypothesized to reduce the risks of skin cancer, concerns have paradoxically been raised about a potential cancer risk following publication of an anecdotal case study in which development of melanoma was observed in a patient who used MT-II [25]

Major side effects such as renal failure or blood poisoning may develop if a patient is given a dosage that is far higher than recommended